Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 111.53 Bn | 109.67 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.57 Bn | 35.83 Bn | 1.97 Bn | 71.83% |
| 3 | Zoetis | 33.84 Bn | 31.90 Bn | 1.62 Bn | -0.17% |
| 4 | United Therapeutics | 24.62 Bn | 22.47 Bn | 648.10 Mn | -14.68% |
| 5 | Aurora Cannabis | 17.89 Bn | 17.81 Bn | 33.43 Mn | -90.23% |
| 6 | Neurocrine Biosciences | 15.75 Bn | 14.43 Bn | 800.70 Mn | 2,405.06% |
| 7 | Regencell Bioscience Holdings | 13.55 Bn | 13.55 Bn | - | - |
| 8 | Elanco Animal Health | 10.61 Bn | 10.18 Bn | 785.00 Mn | -14.93% |
| 9 | HUTCHMED (China) | 10.36 Bn | 9.02 Bn | - | - |
| 10 | Alkermes | 6.14 Bn | 5.63 Bn | -116.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.83% |
| Dec 31, 2025 | 265.25% |
| Sep 30, 2025 | 160.11% |
| Jun 30, 2025 | 125.37% |
| Mar 31, 2025 | -16.14% |
| Dec 31, 2024 | -83.12% |
| Sep 30, 2024 | -40.71% |
| Jun 30, 2024 | 30.90% |
| Mar 31, 2024 | 125.30% |
| Dec 31, 2023 | 92.76% |
| Sep 30, 2023 | 26.35% |
| Jun 30, 2023 | -46.21% |
| Mar 31, 2023 | 46.85% |
| Dec 31, 2022 | -90.51% |
| Sep 30, 2022 | -1.33% |
| Jun 30, 2022 | -37.58% |
| Mar 31, 2022 | -111.53% |
| Dec 31, 2021 | -844.67% |
| Sep 30, 2021 | 84.41% |
| Jun 30, 2021 | -655.00% |
| Mar 31, 2021 | -1,394.20% |
| Dec 31, 2020 | 36.36% |
| Sep 30, 2020 | -1,285.03% |
| Jun 30, 2020 | 120.32% |
| Mar 31, 2020 | 165.71% |
| Dec 31, 2019 | 103.74% |
| Sep 30, 2019 | -15.02% |
| Jun 30, 2019 | -185.89% |
| Mar 31, 2019 | -109.95% |
| Dec 31, 2018 | 74.66% |
| Sep 30, 2018 | -151.51% |
| Jun 30, 2018 | 96.01% |
| Mar 31, 2018 | 81.90% |
| Dec 31, 2017 | -1,017.53% |
| Sep 30, 2017 | -100.00% |
| Jun 30, 2017 | -100.00% |
| Mar 31, 2017 | 1.75% |
| Dec 31, 2016 | -314.02% |
| Sep 30, 2016 | 337,863,977.67% |
| Jun 30, 2016 | 34,879,306.31% |
| Mar 31, 2016 | 27.80% |
| Dec 31, 2015 | -29.40% |
| Sep 30, 2015 | -89.61% |
| Jun 30, 2015 | -32.46% |
| Mar 31, 2015 | -51.73% |
| Dec 31, 2014 | 59.77% |
| Sep 30, 2014 | 53.64% |
| Jun 30, 2014 | 245.62% |
| Mar 31, 2014 | 25.03% |
| Dec 31, 2013 | 120.51% |
| Sep 30, 2013 | 401.40% |
| Jun 30, 2013 | -175.17% |
| Mar 31, 2013 | 2.92% |
| Dec 31, 2012 | -48.14% |
| Sep 30, 2012 | -124.91% |
| Jun 30, 2012 | 38.33% |
| Mar 31, 2012 | -0.28% |
| Dec 31, 2011 | -48.14% |
| Sep 30, 2011 | -15.29% |
| Jun 30, 2011 | -31.91% |
| Mar 31, 2011 | 4.50% |
| Dec 31, 2010 | 104.23% |
| Sep 30, 2010 | 64.88% |
| Jun 30, 2010 | 52.36% |
| Mar 31, 2010 | 104.39% |